A FUSION OF NUP214 TO ABL1 ON AMPLIFIED EPISOMES IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: CASE REPORT AND LITERATURE REVIEW
Objective: We describe a NUP214::ABL1 fusion identified in a case of T-cell Acute Lymphoblastic Leukemia (T-ALL). Methodology: The clinical data of a NUP214::ABL1 fusion gene-positive T-ALL patient were retrospectively analyzed. Results: A 13-year-old girl was admitted to our hospital complaining of...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137925001476 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849709391703441408 |
|---|---|
| author | Jiantuo Liu Hongrui Li Li Jiang Xiangjun Chen Yanli He |
| author_facet | Jiantuo Liu Hongrui Li Li Jiang Xiangjun Chen Yanli He |
| author_sort | Jiantuo Liu |
| collection | DOAJ |
| description | Objective: We describe a NUP214::ABL1 fusion identified in a case of T-cell Acute Lymphoblastic Leukemia (T-ALL). Methodology: The clinical data of a NUP214::ABL1 fusion gene-positive T-ALL patient were retrospectively analyzed. Results: A 13-year-old girl was admitted to our hospital complaining of lower limb edema and leukocytosis. She displayed recurrent edema of both thighs accompanied by cough. A peripheral blood examination showed the following counts: White Blood Cell Count (WBC) 352.5 × 109/L, Neutrophil count 267.91 × 109/L, Lymphocyte count 83.19 × 109/L, Red Blood Cell Count (RBC) 2.2 × 1012/L, hemoglobin 67g/L, platelet count 79 × 109/L, and C-Reactive Protein (CRP) 12.52 mg/L. Leukemic blasts accounted for 90% of the bone-marrow cells. The patient demonstrated a T-cell phenotype, and showed expression of CD2, CD3(dim), CD4, CD5, CD7(bri), CD10, CD34, CD38, CD99 and cCD3. A G-band-staining chromosomal analysis revealed normal karyotype. A Fluorescence In Situ Hybridization (FISH) analysis revealed ABL1 amplification (Fig. 1). A ph-like ALL33 fusion gene screening analysis discovered NUP214::ABL1 fusion. In conclusion, the child definitive diagnosed T-ALL with NUP214::ABL1 fusion. Complete remission was achieved after T-ALL induction therapy with vincristine, dexamethasone, PEG-L-asparaginase, daunorubicin, cyclophosphamide, cytarabine, mercaptopurine and dasatinib. To follow-up date, the patient's condition was stable in consolidation therapy phase. Conclusions: NUP214::ABL1 fusion is present in 6% of T-ALL cases in both children and adults, it is cryptic by conventional cytogenetics but detected by FISH using a ABL1 probe. FISH analysis reveals multiple extrachromosomal ABL1 sites in metephase cells and amplified ABL1 signals in interphase cells. The amplified signals or episomes are the result of the excision of the 9q34 region between the ABL1 and NUP214 breakpoints followed by circularization of the fragment. NUP214::ABL1 fusion T-ALL represents a distinct form of high-risk leukaemia with early replase and poor prognosis. Because the ABL1 fusions are sensitive to Tyrosine Kinase Inhibitors (TKIs), the strategy of conventional chemotherapy with TKIs can improve outcome in NUP214::ABL1 fusion T-ALL. |
| format | Article |
| id | doaj-art-e9d932d9a0684a4b971728b66163effb |
| institution | DOAJ |
| issn | 2531-1379 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Hematology, Transfusion and Cell Therapy |
| spelling | doaj-art-e9d932d9a0684a4b971728b66163effb2025-08-20T03:15:19ZengElsevierHematology, Transfusion and Cell Therapy2531-13792025-07-014710387910.1016/j.htct.2025.103879A FUSION OF NUP214 TO ABL1 ON AMPLIFIED EPISOMES IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: CASE REPORT AND LITERATURE REVIEWJiantuo Liu0Hongrui Li1Li Jiang2Xiangjun Chen3Yanli He4Wuhan Kindstar Medical Laboratory Co, LtdWuhan Kindstar Medical Laboratory Co, LtdWuhan Kindstar Medical Laboratory Co, LtdUnion Hospital, Tongji Medical College HUSTUnion Hospital, Tongji Medical College HUSTObjective: We describe a NUP214::ABL1 fusion identified in a case of T-cell Acute Lymphoblastic Leukemia (T-ALL). Methodology: The clinical data of a NUP214::ABL1 fusion gene-positive T-ALL patient were retrospectively analyzed. Results: A 13-year-old girl was admitted to our hospital complaining of lower limb edema and leukocytosis. She displayed recurrent edema of both thighs accompanied by cough. A peripheral blood examination showed the following counts: White Blood Cell Count (WBC) 352.5 × 109/L, Neutrophil count 267.91 × 109/L, Lymphocyte count 83.19 × 109/L, Red Blood Cell Count (RBC) 2.2 × 1012/L, hemoglobin 67g/L, platelet count 79 × 109/L, and C-Reactive Protein (CRP) 12.52 mg/L. Leukemic blasts accounted for 90% of the bone-marrow cells. The patient demonstrated a T-cell phenotype, and showed expression of CD2, CD3(dim), CD4, CD5, CD7(bri), CD10, CD34, CD38, CD99 and cCD3. A G-band-staining chromosomal analysis revealed normal karyotype. A Fluorescence In Situ Hybridization (FISH) analysis revealed ABL1 amplification (Fig. 1). A ph-like ALL33 fusion gene screening analysis discovered NUP214::ABL1 fusion. In conclusion, the child definitive diagnosed T-ALL with NUP214::ABL1 fusion. Complete remission was achieved after T-ALL induction therapy with vincristine, dexamethasone, PEG-L-asparaginase, daunorubicin, cyclophosphamide, cytarabine, mercaptopurine and dasatinib. To follow-up date, the patient's condition was stable in consolidation therapy phase. Conclusions: NUP214::ABL1 fusion is present in 6% of T-ALL cases in both children and adults, it is cryptic by conventional cytogenetics but detected by FISH using a ABL1 probe. FISH analysis reveals multiple extrachromosomal ABL1 sites in metephase cells and amplified ABL1 signals in interphase cells. The amplified signals or episomes are the result of the excision of the 9q34 region between the ABL1 and NUP214 breakpoints followed by circularization of the fragment. NUP214::ABL1 fusion T-ALL represents a distinct form of high-risk leukaemia with early replase and poor prognosis. Because the ABL1 fusions are sensitive to Tyrosine Kinase Inhibitors (TKIs), the strategy of conventional chemotherapy with TKIs can improve outcome in NUP214::ABL1 fusion T-ALL.http://www.sciencedirect.com/science/article/pii/S2531137925001476NUP214::ABL1ABL1 amplificationT-ALLFISH |
| spellingShingle | Jiantuo Liu Hongrui Li Li Jiang Xiangjun Chen Yanli He A FUSION OF NUP214 TO ABL1 ON AMPLIFIED EPISOMES IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: CASE REPORT AND LITERATURE REVIEW Hematology, Transfusion and Cell Therapy NUP214::ABL1 ABL1 amplification T-ALL FISH |
| title | A FUSION OF NUP214 TO ABL1 ON AMPLIFIED EPISOMES IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: CASE REPORT AND LITERATURE REVIEW |
| title_full | A FUSION OF NUP214 TO ABL1 ON AMPLIFIED EPISOMES IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: CASE REPORT AND LITERATURE REVIEW |
| title_fullStr | A FUSION OF NUP214 TO ABL1 ON AMPLIFIED EPISOMES IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: CASE REPORT AND LITERATURE REVIEW |
| title_full_unstemmed | A FUSION OF NUP214 TO ABL1 ON AMPLIFIED EPISOMES IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: CASE REPORT AND LITERATURE REVIEW |
| title_short | A FUSION OF NUP214 TO ABL1 ON AMPLIFIED EPISOMES IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: CASE REPORT AND LITERATURE REVIEW |
| title_sort | fusion of nup214 to abl1 on amplified episomes in t cell acute lymphoblastic leukemia case report and literature review |
| topic | NUP214::ABL1 ABL1 amplification T-ALL FISH |
| url | http://www.sciencedirect.com/science/article/pii/S2531137925001476 |
| work_keys_str_mv | AT jiantuoliu afusionofnup214toabl1onamplifiedepisomesintcellacutelymphoblasticleukemiacasereportandliteraturereview AT hongruili afusionofnup214toabl1onamplifiedepisomesintcellacutelymphoblasticleukemiacasereportandliteraturereview AT lijiang afusionofnup214toabl1onamplifiedepisomesintcellacutelymphoblasticleukemiacasereportandliteraturereview AT xiangjunchen afusionofnup214toabl1onamplifiedepisomesintcellacutelymphoblasticleukemiacasereportandliteraturereview AT yanlihe afusionofnup214toabl1onamplifiedepisomesintcellacutelymphoblasticleukemiacasereportandliteraturereview AT jiantuoliu fusionofnup214toabl1onamplifiedepisomesintcellacutelymphoblasticleukemiacasereportandliteraturereview AT hongruili fusionofnup214toabl1onamplifiedepisomesintcellacutelymphoblasticleukemiacasereportandliteraturereview AT lijiang fusionofnup214toabl1onamplifiedepisomesintcellacutelymphoblasticleukemiacasereportandliteraturereview AT xiangjunchen fusionofnup214toabl1onamplifiedepisomesintcellacutelymphoblasticleukemiacasereportandliteraturereview AT yanlihe fusionofnup214toabl1onamplifiedepisomesintcellacutelymphoblasticleukemiacasereportandliteraturereview |